BridgeMD
Tests treatment safety and results for Chronic Low Back Pain
Official title Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain
ClinicalTrials.gov ID: NCT07241559
What this study is testing
What is 5% dextrose injection?
5% dextrose injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for chronic low back pain.
Also referred to as Ultrasound-Guided 5% Dextrose Injection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain. -Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Male or female patients aged 18 to 65 years
- Presence of low back pain lasting longer than 3 months
- No adequate response to medical treatment
- Voluntary participation in the study
You likely can't join if
- Age below 18 or above 65 years
- Body mass index (BMI) greater than 30 kg/m²
- Pregnancy or breastfeeding
- Presence of coagulation disorders
- History of spinal surgery
- Presence of inflammatory or malignant diseases
See the full eligibility criteria
- Male or female patients aged 18 to 65 years
- Presence of low back pain lasting longer than 3 months
- No adequate response to medical treatment
- Voluntary participation in the study
- Age below 18 or above 65 years
- Body mass index (BMI) greater than 30 kg/m²
- Pregnancy or breastfeeding
- Presence of coagulation disorders
- History of spinal surgery
- Presence of inflammatory or malignant diseases
- Local infection at the spine or injection site
- Presence of lumbar disc pathology causing radiculopathy
- Presence of spinal stenosis, spondylolysis, or spondylolisthesis
- Participation in physical therapy or any manual therapy within the past 6 months
- Receiving lumbar injections within the past 6 months
- History of allergy to injection materials
- Refusal to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Altındağ, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Altındağ, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.